What medications are recommended for treating lower back muscle spasms?

Medications for Lower Back Spasms

For acute lower back spasms, start with NSAIDs as first-line therapy, and add a skeletal muscle relaxant for short-term use (≤2 weeks) if NSAIDs alone provide insufficient relief. 1, 2

First-Line Treatment Approach

NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)

• NSAIDs are more effective than acetaminophen for acute low back pain with muscle spasm 1
• Provide moderate pain relief with a reduction of approximately 7 points on a 0-100 pain scale at 2-4 days 2
• Use the lowest effective dose for the shortest duration necessary
• Critical caveat: Assess cardiovascular and gastrointestinal risk factors before prescribing, as NSAIDs carry risks for MI, GI bleeding, and renal complications 1

Why NOT Acetaminophen First

High-certainty evidence shows acetaminophen provides no benefit over placebo for acute low back pain (pain difference of only 0.49 points on 0-100 scale, which is clinically meaningless) 3, 4. Despite being traditionally recommended for safety, it simply doesn't work for this indication.

Second-Line: Skeletal Muscle Relaxants

Add a muscle relaxant when NSAIDs alone are insufficient, particularly when muscle spasm is prominent 1, 2:

Efficacy

• Moderately superior to placebo for short-term pain relief (2-4 days) 2
• Risk ratio of 0.80 for not achieving pain relief compared to placebo 2
• Combination therapy (NSAID + muscle relaxant) works better than NSAID alone for objective muscle spasm, tenderness, and range of motion 5, 6

Specific Agents

No single muscle relaxant is clearly superior to others 1, 2, but consider these distinctions:

• Cyclobenzaprine: Most studied, efficacy independent of sedative effects (though sedation is dose-related) 7
• Carisoprodol 250mg: Effective with faster onset (3 days vs 6 days for placebo), but metabolized to meprobamate with abuse potential 1, 8, 7
• Tizanidine: Well-studied for low back pain in 8 trials, though carries hepatotoxicity risk (usually reversible) 1, 2
• Avoid: Baclofen and dantrolene have sparse evidence for low back pain 2

Duration and Safety

• Limit use to ≤2 weeks maximum - all trials were 2 weeks or less 2
• Central nervous system adverse events are common (sedation primarily) with RR 2.04 vs placebo 2
• Serious complications are rare 2

Third-Line Options (Use Judiciously)

Opioids

Reserve for severe, disabling pain uncontrolled by NSAIDs and muscle relaxants 1:

• Only modest short-term benefits for chronic pain (8-point reduction on 0-100 scale) 2
• Substantial risks: abuse, addiction, tolerance, sedation, constipation 1, 9
• Time-limited course only; failure to respond warrants reassessment 1
• No evidence one opioid is superior to another 1

What NOT to Use

Benzodiazepines: Similarly effective to muscle relaxants for short-term relief BUT carry higher risks for abuse, addiction, and tolerance 1. Not FDA-approved for low back pain. If used at all, strictly time-limited.

Systemic corticosteroids: Not recommended - no more effective than placebo 1, 3

Gabapentin/antiepileptics: Only small benefits for radiculopathy specifically, not for simple muscle spasm 1, 2, 1

Critical Clinical Pitfalls

1. Don't continue muscle relaxants beyond 2 weeks - no evidence supports longer use and sedation risks accumulate 2

2. Don't prescribe muscle relaxants believing they actually relax muscles - their mechanism is nonspecific and not related to true muscle relaxation 10

3. Don't use opioids as first-line - the risk-benefit ratio only favors them after other options have failed 1, 9

4. Don't forget cardiovascular screening before NSAIDs - increased MI risk with most NSAIDs 1

5. Reassess if no improvement occurs - failure to respond should trigger consideration of alternative diagnoses or referral 1

Practical Algorithm

1. Start: NSAID (assess CV/GI risk first)
2. If insufficient at 2-4 days: Add muscle relaxant (cyclobenzaprine or carisoprodol 250mg)
3. Duration: Continue combination maximum 2 weeks
4. If still inadequate: Consider time-limited opioid trial OR reassess diagnosis
5. Chronic symptoms (>12 weeks): Transition to different strategy (tricyclic antidepressants, duloxetine) 1